CEFAZOLIN SODIUM USP
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | CEFAZOLIN SODIUM USP |
| DrugBank ID | DB01327 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 60 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| congestive heart failure | TxGNN Knowledge Graph | L5 |
| hypertension | TxGNN Knowledge Graph | L5 |
| hypertensive disorder | TxGNN Knowledge Graph | L5 |
| bronchitis | TxGNN Knowledge Graph | L5 |
| gingivitis | TxGNN Knowledge Graph | L5 |
| chancroid | TxGNN Knowledge Graph | L5 |
| necrotizing ulcerative gingivitis | TxGNN Knowledge Graph | L5 |
| actinomycetales infectious disease | TxGNN Knowledge Graph | L5 |
| granuloma inguinale | TxGNN Knowledge Graph | L5 |
| syphilis | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11